Cosmo Bio Company,Limited Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	10,766	10,037	9,340	9,553	9,231
Revenue Growth (YoY)	7.26%	7.46%	-2.23%	3.49%	14.08%
Cost of Revenue	7,064	6,708	6,090	6,112	5,572
Gross Profit	3,702	3,329	3,250	3,441	3,659
Selling, General & Admin	3,359	3,010	2,729	2,624	2,609
Operating Expenses	3,359	3,010	2,729	2,624	2,609
Operating Income	343	319	521	817	1,050
Interest & Investment Income	101	75	71	44	40
Currency Exchange Gain (Loss)	13	-33	-	-49	-15
Other Non Operating Income (Expenses)	32	5	33	7	23
EBT Excluding Unusual Items	489	366	625	819	1,098
Gain (Loss) on Sale of Investments	69	5	-	-	-
Gain (Loss) on Sale of Assets	-54	-	-	-	-
Asset Writedown	-	-3	27	-29	-
Pretax Income	504	368	652	790	1,098
Income Tax Expense	170	99	191	238	330
Earnings From Continuing Operations	334	269	461	552	768
Minority Interest in Earnings	3	-7	-19	-35	-31
Net Income	337	262	442	517	737
Net Income to Common	337	262	442	517	737
Net Income Growth	28.63%	-40.72%	-14.51%	-29.85%	9.35%
Shares Outstanding (Basic)	6	6	6	6	6
Shares Outstanding (Diluted)	6	6	6	6	6
Shares Change (YoY)	-2.21%	-0.22%	0.40%	-0.06%	-2.01%
EPS (Basic)	59.26	45.05	75.83	89.06	126.88
EPS (Diluted)	59.26	45.05	75.83	89.06	126.88
EPS Growth	31.54%	-40.59%	-14.85%	-29.81%	11.59%
Free Cash Flow	-	25	669	229	617
Free Cash Flow Per Share	-	4.30	114.78	39.45	106.22
Dividend Per Share	-	50.000	30.000	36.000	36.000
Dividend Growth	-	66.67%	-16.67%	-	5.88%
Gross Margin	34.39%	33.17%	34.80%	36.02%	39.64%
Operating Margin	3.19%	3.18%	5.58%	8.55%	11.38%
Profit Margin	3.13%	2.61%	4.73%	5.41%	7.98%
Free Cash Flow Margin	-	0.25%	7.16%	2.40%	6.68%
EBITDA	479	455	669	958	1,216
EBITDA Margin	4.45%	4.53%	7.16%	10.03%	13.17%
D&A For EBITDA	136	136	148	141	166
EBIT	343	319	521	817	1,050
EBIT Margin	3.19%	3.18%	5.58%	8.55%	11.38%
Effective Tax Rate	33.73%	26.90%	29.29%	30.13%	30.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.